Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Class of Diabetes Drugs Effective in Controlling Blood Glucose Posted: Saturday, June 30, 2007

First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes.

Statins and Fibrates Prevents Diabetic Neuropathy by 48% Posted: Saturday, June 30, 2007

A major epidemiological study conducted over eight years in Australia has shown that two classes of lipid-lowering drugs - statins and fibrates - significantly lower the risk of developing nerve damage known as peripheral sensory diabetic neuropathy.

New Drug Cycloset Improves Glucose Control and Reduces CVD Risk Posted: Saturday, June 30, 2007

A quick release formulation of bromocriptine mesylate in patients with type 2 diabetes improves glycemic control and reduces diabetic cardiovascular complications.

Diabetes a Risk Factor for Cardiovascular Morbidity and Mortality in 3.3 Million Subjects Posted: Saturday, June 30, 2007

A new study concludes that patients with type 2 diabetes 30 years of age and older who are receiving glucose-reducing treatment should also receive prompt intensive prophylactic treatment for cardiovascular disease.

Once Weekly Dosing GLP-1 Promotes Beta-Cell Growth Posted: Saturday, June 30, 2007

Preclinical data suggests a long-acting formulation of native, human GLP-1 can promote the growth of insulin producing cells (beta cells) in a type 1 diabetes animal model.

Cheap Fructose May Exact High Metabolic Price Posted: Saturday, June 30, 2007

Fructose in sodas and other beverages -- but not glucose -- can set patients on the fast track to atherosclerosis, investigators here reported.

Patients Beat Physicians at Insulin Dose Adjustment Posted: Saturday, June 30, 2007

Type 2 diabetes patients taught to titrate their own insulin detemir (Levemir) dose may equal or exceed the results that physicians achieve, researchers reported.

Blood Glucose Monitoring for Non-Insulin Users Shows No Benefits Posted: Saturday, June 30, 2007

Regular self-monitoring of blood glucose, at least by people with type 2 diabetes who do not use insulin injections, did not result in a clinically significant reduction in blood glucose control in a year-long study.

Fetus At Risk At Lower Levels of Maternal Blood Glucose Than Thought Posted: Saturday, June 30, 2007

New Findings Likely to Lead to More Diagnoses of Gestational Diabetes.

First Use of Cord Blood to Alter Course of Type 1 Diabetes Posted: Saturday, June 30, 2007

Yields Insights for Developing Future Cocktail to Treat the Disease. Transfusion of the person's own cord blood into newly diagnosed Type 1's, reduced the severity of their diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.